In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies

European Journal of Immunology

Volumn 30, Issue 1, 2000, Pages 1-7

  Hoerr, Ingmar ^a   Obst, Reinhard ^a   Rammensee, Hans Georg ^a   Jung, Günther ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CTL induction; RNA library; RNA protection; RNA vaccine; galactosidase

Indexed keywords

BETA GALACTOSIDASE; IMMUNOGLOBULIN G ANTIBODY; LIPOSOME; RNA; VACCINE;

ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DNA LIBRARY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IMMUNIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

XENOPUS LAEVIS;

EID: 0033989908     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200001)30:1<1::aid-immu1>3.0.co;2-%23     Document Type: Article

References (27)

1. Boon, T., Coulie, P. G. and Van-Den-Eynde, B., Tumor antigens recognized by T cells. Immunol. Today 1997. 18: 267-268.
2. Schild, H., Arnold-Schild, D., Lammert, E. and Rammensee, H.-G., Stress proteins and immunity by cytotoxic T lymphocytes. Curr. Opin. Immunol. 1999. 11: 109-113.
3. Boczkowski, D., Nair, S. K., Snyder, D. and Gilboa, E., Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 1996. 184: 465-472.
4. Liu, M. A., Fu, T. M., Donnelly, J. J., Caulfield, M. J. and Ulmer, J. B., DNA vaccines. Mechanisms for generation of immune responses. Adv. Exp. Med. Biol. 1998. 452: 187-191.
5. Mandl, C. W., Aberle, J. H., Aberle, S. W., Holzmann, H., Allison, S. L. and Heinz, F., In vitro synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nature Med. 1998. 4: 1438-1440.
6. Deres, K., Schild, H., Wiesmüller, K.-H., Jung, G. and Rammensee, H.-G., In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989. 342: 561-564.
7. Lu, D., Benjamin, R., Kim, M., Conry, R. M. and Curiel, D. T., Optimization of methods to achieve mRNA mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther. 1994. 4: 245-252.
8. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G. and Felgner, P. L., Direct gene transfer into mouse muscle in vivo. Science 1990. 257: 1465-1468.
9. Martinon, F., Krishnan, S., Lenzen, G., Magné, R., Gomard, E., Guillet, J.-G., Lévy, J.-P. and Meulien, P., Induction of virus specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur. J. Immunol. 1993. 23: 1719-1722.
10. Conry, R. M., LoBuglio, A. F., Wright, M., Sumerel, L., Pike, M. J., Johanning, F., Benjamin, R., Lu, D. and Curiel, D. T., Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res. 1995. 55: 1397-1400.
11. Malone, R. W., Felgner, P. L. and Verma, I., Cationic liposome-mediated RNA transfection. Proc. Natl. Acad. Sci. USA 1989. 86: 6077-6081.
12. Strong, T. V., Hampton, T. A., Lauro, I., Bilbao, G., Conry, R. M. and Curiel, D. T., Incorporation of β-globin untranslated regions into a sindbis virus vector for augmentation of heterologous mRNA expression. Gene Ther. 1997. 4: 624-627.
13. Iezzi, G., Karjalainen, K. and Lanzavecchia, A., The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 1998. 8: 89-95.
14. Toes, R. E. M., Blom, R. J. J., Van-Der-Voort, E., Offringa, R., Melief, C. J. M. and Kast, W. M., Protective antitumor immunity induced by immunization with completely allogeneic tumor cells. Cancer Res. 1996. 56: 3782-3787.
15. Falk, K., Rötzschke, O., Faath, S., Goth, S., Graef, I., Shastri, N. and Rammensee, H.-G., Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL. Cell. Immunol. 1993. 150: 447-452.
16. Oukka, M., Cohen-Tannoudji, M., Tanaka, Y., Babinet, C. and Kosmatopoulos, K., Medullary thymic epithelial cells induce tolerance to intracellular proteins. J. Immunol. 1996. 156: 968-975.
17. Warrant, R. W. and Kim, S. H., Alpha-Helix-double helix interaction shown in the structure of a protamine-transfer RNA complex and a nucleoprotamine model. Nature 1978. 27: 130-135.
18. Gavin, M. A., Gilbert, M. J., Riddell, S. R., Greenberg, P. D. and Bevan, M. J., Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 1993. 151: 3971-3980.
19. Montgomery, D. L., Shiver, J. W., Leander, K. R., Perry, H. C., Friedman, A., Martinez, D., Ulmer, J. B., Donnelly, J. J. and Liu, M. A., Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol. 1993. 12: 777-783.
20. Martins, L. P., Lau, L. L., Asano, M. S. and Ahmed, R., DNA vaccination against persistent viral infection. J. Virol. 1995. 69: 2574-2582.
21. Gilkeson, G. S., Pippen, A. M. and Pisetsky, D. S., Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/ NZW mice by immunization with bacterial DNA. J. Clin. Invest. 1995. 95: 1398-1402.
22. Förg, P., von Hoegen, P., Dalemans, W. and Schirrmacher, V., Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther. 1998. 5: 789-797.
23. Filion, M. C. and Phillips, N. C., Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim. Biophys. Acta 1997. 1329: 345-356.
24. Tamura, Y., Peng, P., Liu, K., Daou, M. and Srivastava, P. K., Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997. 278: 117-120.
25. Carbone, F. R. and Bevan, M. J., Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 1990. 171: 377-387.
26. Schild, H., Norda, M., Deres, K., Falk, K., Rötzschke, O., Wiesmüller, K.-H., Jung, G. and Rammensee, H.-G., Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide. J. Exp. Med. 1991. 174: 1665-1668.
27. Rammensee, H.-G., Schild, H. and Theopold, U., Protein-specific cytotoxic T lymphocytes. Recognition of transfectants expressing intracellular, membrane-associated or secreted forms of β-galactosidase. Immunogenetics 1989. 30: 296-302.